Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Glenmark Pharmaceuticals Limited
Press Release Nov 02 2022
Business
Nov 2 2022
4 min read

Press Release Nov 02 2022

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 02-Nov-2022 titled Glenmark Pharmaceuticals receives ANDA approval for Sodium Phenylbutyrate Tablets USP, 500 mg

View Attachment